# 2026-04296: Catalent Applies to Import Psilocybin for U.S. Market

2026-04296, Importer of Controlled Substances Application: Catalent Greenville, Inc., is a Federal Register notice from Justice Department, Drug Enforcement Administration published 2026-03-04, effective Registered bulk manufacturers of the affected basic class(es), and applicants, therefore, may submit electronic comments on or objections to the issuance of the proposed registration on or before April 3, 2026. Such persons may also file a written request for a hearing on the application on or before April 3, 2026. (as of 2026-06-08).

- Canonical: https://policyrisk.com/federal-register/2026-04296
- As of: 2026-06-08
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2026-04296
- Title: Importer of Controlled Substances Application: Catalent Greenville, Inc.
- Type: Notice
- Agencies: Justice Department; Drug Enforcement Administration
- Citation: 91 FR 10626
- Published: 2026-03-04
- Effective: Registered bulk manufacturers of the affected basic class(es), and applicants, therefore, may submit electronic comments on or objections to the issuance of the proposed registration on or before April 3, 2026. Such persons may also file a written request for a hearing on the application on or before April 3, 2026.
- Comments close: 2026-04-03
- Significant: no
- Touches household money: no
- Regulation identifier numbers: none
- Last updated: 2026-06-08

## In one line

Catalent Applies to Import Psilocybin for U.S. Market

## Summary

Catalent Greenville, Inc. wants to become an official importer of psilocybin, a controlled substance. This affects companies involved in drug manufacturing and importation, who can comment or request a hearing by April 3, 2026. No direct costs are mentioned, but the decision could impact the controlled substances market.

## Abstract

Catalent Greenville, Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

## Effects PRIA read

No economic effects identified for this document.

## Related documents

- [2026-11526](https://policyrisk.com/federal-register/2026-11526): Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 201…, 2026-06-09
- [2026-10128](https://policyrisk.com/federal-register/2026-10128): Revision of Applications for Manufacturing and Procurement Quotas, 2026-05-20
- [2025-05007](https://policyrisk.com/federal-register/2025-05007): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-03-24
- [2025-02793](https://policyrisk.com/federal-register/2025-02793): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-02-19
- [2026-22843](https://policyrisk.com/federal-register/2026-22843): Proposed Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ep…, 2026-11-10
- [2026-22842](https://policyrisk.com/federal-register/2026-22842): Adjustment to the 2026 Aggregate Production Quota for d,l-Amphetamine, d-Amphetamine (for Sale), Hydromorphone and Methylphenidate (for Sal…, 2026-11-10

## Sources
- [2026-04296 on federalregister.gov](https://www.federalregister.gov/documents/2026/03/04/2026-04296/importer-of-controlled-substances-application-catalent-greenville-inc)
- [2026-04296 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2026-03-04/pdf/2026-04296.pdf)

## Related
- [Previous: 2026-04295, Extension of a Currently Approved Information Collection: Agreement and Request…](https://policyrisk.com/federal-register/2026-04295)
- [Next: 2026-04297, Notice of Availability of FAA Notice N 8100.20 Regarding Organization Designati…](https://policyrisk.com/federal-register/2026-04297)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2026-04296 (as of 2026-06-08).
